Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator.

Shady M Abd El-HalimGhada A AbdelbaryMaha M AminMohamed Y ZakariaHesham A Shamsel-DinAhmed B Ibrahim

Published in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2020)

NLCs could be successfully used as oral drug delivery carriers of the antiviral drug Adefovir Dipivoxil to the liver with higher stability and oral bioavailability. Graphical abstract.

Keyphrases

drug delivery
cancer therapy
high dose
fatty acid
risk assessment
climate change
drug release
adverse drug
electronic health record